These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1368228)

  • 1. High level Escherichia coli expression and production of a bivalent humanized antibody fragment.
    Carter P; Kelley RF; Rodrigues ML; Snedecor B; Covarrubias M; Velligan MD; Wong WL; Rowland AM; Kotts CE; Carver ME
    Biotechnology (N Y); 1992 Feb; 10(2):163-7. PubMed ID: 1368228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High level expression of chimeric antibody fragment F(ab')2 directed against CD20 in Escherichia coli].
    Xiong DS; Zheng MJ; Liu YX; Xu YF; Wang JH; Yang CZ
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):673-8. PubMed ID: 15973988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.
    Rodrigues ML; Snedecor B; Chen C; Wong WL; Garg S; Blank GS; Maneval D; Carter P
    J Immunol; 1993 Dec; 151(12):6954-61. PubMed ID: 7903100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
    Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
    Better M; Bernhard SL; Lei SP; Fishwild DM; Lane JA; Carroll SF; Horwitz AH
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):457-61. PubMed ID: 7678457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of dimeric F(ab) useful in blood group serology.
    Czerwinski M; Krop-Watorek A; Lisowska E; Spitalnik SL
    Transfusion; 2002 Feb; 42(2):257-64. PubMed ID: 11896344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering linear F(ab')2 fragments for efficient production in Escherichia coli and enhanced antiproliferative activity.
    Zapata G; Ridgway JB; Mordenti J; Osaka G; Wong WL; Bennett GL; Carter P
    Protein Eng; 1995 Oct; 8(10):1057-62. PubMed ID: 8771187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F(ab')2 molecules made from Escherichia coli produced Fab' with hinge sequences conferring increased serum survival in an animal model.
    Humphreys DP; Vetterlein OM; Chapman AP; King DJ; Antoniw P; Suitters AJ; Reeks DG; Parton TA; King LM; Smith BJ; Lang V; Stephens PE
    J Immunol Methods; 1998 Aug; 217(1-2):1-10. PubMed ID: 9776570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level secretion of a humanized bispecific diabody from Escherichia coli.
    Zhu Z; Zapata G; Shalaby R; Snedecor B; Chen H; Carter P
    Biotechnology (N Y); 1996 Feb; 14(2):192-6. PubMed ID: 9636323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single chain Fab (scFab) fragment.
    Hust M; Jostock T; Menzel C; Voedisch B; Mohr A; Brenneis M; Kirsch MI; Meier D; Dübel S
    BMC Biotechnol; 2007 Mar; 7():14. PubMed ID: 17346344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level production and secretion of a mouse-human chimeric Fab fragment with specificity to human carcino embryonic antigen in Escherichia coli.
    Shibui T; Munakata K; Matsumoto R; Ohta K; Matsushima R; Morimoto Y; Nagahari K
    Appl Microbiol Biotechnol; 1993 Mar; 38(6):770-5. PubMed ID: 7763534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.
    Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U
    Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional antibody Fv and Fab fragments in Escherichia coli.
    Plückthun A; Skerra A
    Methods Enzymol; 1989; 178():497-515. PubMed ID: 2689841
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of recombinant chimeric B72.3 Fab' and F(ab')2 using streptococcal protein G.
    Proudfoot KA; Torrance C; Lawson AD; King DJ
    Protein Expr Purif; 1992 Oct; 3(5):368-73. PubMed ID: 1458050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable, genetically engineered F(ab')(2) fragments of chimeric TNT-3 expressed in mammalian cells.
    Khawli LA; Biela BH; Hu P; Epstein AL
    Hybrid Hybridomics; 2002 Feb; 21(1):11-8. PubMed ID: 11991812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli.
    Cabilly S
    Gene; 1989 Dec; 85(2):553-7. PubMed ID: 2697647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and tumor-seeking properties of recombinant and nonrecombinant anti-carcinoembryonic antigen antibody fragments.
    Groulet A; Dorvillius M; Pèlegrin A; Barbet J; Baty D
    Int J Cancer; 2002 Jul; 100(3):367-74. PubMed ID: 12115555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high yielding E. coli periplasmic expression system for the production of humanized Fab' fragments.
    Ellis M; Patel P; Edon M; Ramage W; Dickinson R; Humphreys DP
    Biotechnol Prog; 2017 Jan; 33(1):212-220. PubMed ID: 27790865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments.
    Skerra A
    Gene; 1994 Apr; 141(1):79-84. PubMed ID: 8163179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.